Insider trades

David Zaccardelli, Director of SAB Biotherapeutics SABS, has filed 0 purchases and 36 sales on the open market. The latest trade was on 01/05.

David Zaccardelli

Director
First filing
23/02/03
Trades
71 trades
Buys / sales
0 / 36
12-month net buying
No record
Last trade
01/05

Trading activity

Transactions

Trade type
Open-market sale10b5-1 plan25/08/0125/08/05208,912 sh$13.14$2,745,103.68−1.5%
Open-market sale10b5-1 plan25/06/1125/06/13400,000 sh$11.40$4,560,000−2.9%
Open-market sale10b5-1 plan25/05/27–25/05/2925/05/29400,000 sh3 trades$9.33avg.$3,733,988.88−2.9%
Open-market sale10b5-1 plan25/05/01–25/05/0225/05/05587,008 sh3 trades$9.05avg.$5,309,721.6−4.0%
Open-market sale10b5-1 plan25/04/2925/05/0190,360 sh$8.98$811,432.8−0.6%
Open-market sale10b5-1 plan24/12/04–24/12/0624/12/06870,672 sh3 trades$5.01avg.$4,361,390.64−5.8%
Open-market sale10b5-1 plan24/11/27–24/12/0224/12/02125,328 sh3 trades$5.01avg.$627,628.88−0.8%
Open-market sale10b5-1 plan24/11/2524/11/261,600 sh$5.00$8,000−0.0%
Open-market sale10b5-1 plan24/11/1124/11/132,400 sh$5.00$12,000−0.0%
Open-market sale10b5-1 plan24/11/01–24/11/0424/11/05141,032 sh2 trades$4.39avg.$618,661.6−0.9%
Open-market sale10b5-1 plan24/10/23–24/10/2524/10/25144,816 sh3 trades$4.38avg.$634,294.08−1.0%
Open-market sale10b5-1 plan24/10/18–24/10/2224/10/22514,152 sh3 trades$4.38avg.$2,253,564.88−3.4%
Open-market sale10b5-1 plan24/09/1124/09/13600,000 sh$3.76$2,256,000−3.8%
Open-market sale10b5-1 plan24/08/12–24/08/1324/08/14400,000 sh3 trades$3.20avg.$1,280,298.8−2.5%
Open-market sale10b5-1 plan23/08/03–23/08/0723/08/07275,888 sh3 trades$2.52avg.$694,152.4−1.7%
Open-market sale10b5-1 plan23/08/01–23/08/0223/08/03179,648 sh2 trades$2.64avg.$474,823.28−1.1%
Open-market sale10b5-1 plan23/05/0123/05/03455,536 sh$2.58$1,175,282.88−2.6%
Open-market sale23/02/0123/02/03432,928 sh$2.56$1,108,295.68−2.4%